Drug shortage: Sodium Acetate Injection (SODIUM ACETATE, SODIUM ACETATE ANHYDROUS)
FDA lists 15 presentations as Current. Availability: Unavailable (1), Limited Availability (2), Available (12). Reason: Other. Companies: Hospira, Inc., a Pfizer Company, Milla Pharmaceuticals, Fresenius Kabi USA, LLC, Somerset Therapeutics, LLC, Hikma Pharmaceuticals USA, Inc..
- Published by source
- 2016-02-03
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Sodium Acetate Injection SODIUM ACETATE SODIUM ACETATE ANHYDROUS
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD
- Next release November 2026. Check wholesalers for inventory.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2016-02-03
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #941 | new | 2026-10-22 | eb8c3b67e49f…0de683 | f912f2f6f227…108c99 |
Chain head: #1076 8ad5adc30b9b…88ce20